Marry M. van den Heuvel‐Eibrink
Researcher Next ID · RN-033715
Researcher · Biochemistry, Genetics and Molecular Biology
Utrecht, Netherlands
- Works count
- 853
- Citation count
- 29,774
- H-index
- 89
- i10-index
- 441
Research interests
Publications
Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(20)30594-5
Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(20)30582-9
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity
Nature Communications · 2020 · 10.1038/s41467-020-15155-6
Tubuloids derived from human adult kidney and urine for personalized disease modeling
Nature Biotechnology · 2019 · 10.1038/s41587-019-0048-8
Reproductive Function and Outcomes in Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Review
Journal of Clinical Oncology · 2018 · 10.1200/jco.2017.76.3441
The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol
Nature Reviews Urology · 2018 · https://doi.org/10.1038/s41585-018-0100-3
Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium
The Lancet Oncology · 2017 · 10.1016/s1470-2045(17)30026-8
The MLL recombinome of acute leukemias in 2017
Leukemia · 2017 · https://doi.org/10.1038/leu.2017.213
Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy
Journal of Clinical Oncology · 2017 · 10.1200/jco.2016.71.6902
Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes
Nature Genetics · 2017 · https://doi.org/10.1038/ng.3772
Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol
Nature Reviews Urology · 2017 · https://doi.org/10.1038/nrurol.2017.163
Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium
Journal of Clinical Oncology · 2016 · 10.1200/jco.2015.64.3288
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2015.62.8289
Mutations in the SIX1/2 Pathway and the DROSHA/DGCR8 miRNA Microprocessor Complex Underlie High-Risk Blastemal Type Wilms Tumors
Cancer Cell · 2015 · https://doi.org/10.1016/j.ccell.2015.01.002
Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial
The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(14)62395-3
Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis
Blood · 2014 · https://doi.org/10.1182/blood-2013-11-538025
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group
Blood · 2013 · 10.1182/blood-2013-06-509463
The MLL recombinome of acute leukemias in 2013
Leukemia · 2013 · https://doi.org/10.1038/leu.2013.135
NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern
Leukemia · 2013 · https://doi.org/10.1038/leu.2013.87
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
Blood · 2012 · https://doi.org/10.1182/blood-2012-03-362608
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern
Blood · 2011 · https://doi.org/10.1182/blood-2011-04-346643
Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
Nature Genetics · 2010 · https://doi.org/10.1038/ng.641
New insights to the MLL recombinome of acute leukemias
Leukemia · 2009 · https://doi.org/10.1038/leu.2009.33
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
Blood · 2009 · https://doi.org/10.1182/blood-2009-04-215152
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia
Blood · 2009 · https://doi.org/10.1182/blood-2009-01-198416
Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004)
The Lancet Oncology · 2009 · 10.1016/s1470-2045(09)70228-1
A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia
Pediatric Blood & Cancer · 2009 · 10.1002/pbc.21942
Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML
Leukemia · 2008 · https://doi.org/10.1038/leu.2008.313
Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study
Blood · 2007 · https://doi.org/10.1182/blood-2006-10-051342
Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia
The Journal of Pediatrics · 2002 · 10.1067/mpd.2002.125728
Current projects
No projects listed.